Business Standard

Thursday, January 09, 2025 | 05:54 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Review of India's indigenous Covaxin shot underway, WHO says

Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval

Bharat Biotech, Covaxin
Premium

Photo: Shutterstock

Reuters Geneva
A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
 
"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing.
 
Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in